Causality assessment
Showing 1 - 25 of >10,000
Colorectal Cancer Trial in Koege (Influenza vaccine, Pembrolizumab)
Not yet recruiting
- Colorectal Cancer
- Influenza vaccine
- Pembrolizumab
-
Koege, Zealand, DenmarkCenter for Surgical Science, Department of Surgery, Zealand Univ
Jun 9, 2023
Aortic Valve Stenosis Trial in Cleveland (Self-expanding valve (Medtronic Evolut FX), Balloon-expanding valve (Edwards Sapien 3
Not yet recruiting
- Aortic Valve Stenosis
- Self-expanding valve (Medtronic Evolut FX)
- Balloon-expanding valve (Edwards Sapien 3 Ultra)
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Jan 20, 2023
Healthy Adult Subjects, Pharmacokinetics, Safety and Tolerability Trial in Baltimore (Low dose KT07, High dose KT07, Low dose
Completed
- Healthy Adult Subjects
- +2 more
- Low dose KT07
- +3 more
-
Baltimore, MarylandPharmaron
Oct 13, 2022
Understand is COVID-19 Vaccine BNT162b2 is Safe in Indonesia
Not yet recruiting
- COVID-19
- BNT162b2
- (no location specified)
Nov 16, 2022
Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)
Recruiting
- Drug-Induced Acute Liver Injury
- Bicyclol tablets
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 2, 2023
Chronic Disease, Cancer, Dementia Alzheimers Trial (natural aging process)
Not yet recruiting
- Chronic Disease
- +5 more
- natural aging process
- (no location specified)
Mar 30, 2022
Prolonged Pain, EEG, Resting State Functional Connectivity Trial in Aalborg (8% Capsaicin patch, patch)
Completed
- Prolonged Pain, EEG, Resting State Functional Connectivity
- 8% Capsaicin patch
- placebo patch
-
Aalborg, DenmarkAalborg University, Department of Health Sciences and technology
Mar 10, 2022
NTRK Gene Fusion - Positive Advanced or Recurrent Solid
Recruiting
- Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Multiple Locations, JapanMany locations
Jan 20, 2023
Safety of the Herbal Medicines at Inpatient Setting
Recruiting
- Drug Induced Liver Injury
- +2 more
-
Seoul, Korea, Republic ofFive tertiary Korean Medicine Hospital (Jecheon, Yangsan, Gwangj
Apr 4, 2022
Healthy Volunteer Trial in Melbourne (SPN-817, Treatment B, SPN-817, Treatment C, BIS-001, Treatment A)
Completed
- Healthy Volunteer
- SPN-817, Treatment B
- +2 more
-
Melbourne, Victoria, AustraliaNucleus Network
Aug 29, 2022
Drug Vericiguat in Japanese People With Chronic Heart Failure
Recruiting
- Chronic Heart Failure
- Vericiguat (Verquvo, BAY1021189)
- Standard of care
-
Multiple Locations, Many Locations, JapanJapanese registries
Feb 2, 2023
Cancer of Breast, Cardiorespiratory Fitness, Occupational Health Trial
Completed
- Cancer of Breast
- +2 more
- (no location specified)
Feb 6, 2023
Tumors, Bone Marrow Transplantation Trial in Parkville (Release of Extended Pharmacogenomics Report at Week 1, Release of
Not yet recruiting
- Neoplasms
- Bone Marrow Transplantation
- Release of Extended Pharmacogenomics Report at Week 1
- Release of Extended Pharmacogenomics Report at Week 13
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Dec 19, 2022
Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Atorvastatin
- Quadrivalent seasonal influenza vaccine
-
Atlanta, GeorgiaHope Clinic
Aug 29, 2023
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA, 0.25% albumin solution with rHuPH20,
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- HYQVIA
- +2 more
-
Phoenix, Arizona
- +82 more
Feb 28, 2022
Median Sternotomy Trial in Freiburg im Breisgau, Pamplona, Barcelona (Combination of STERN FIX and wires, Wires)
Not yet recruiting
- Median Sternotomy
- Combination of STERN FIX and wires
- Wires
-
Freiburg im Breisgau, Baden-Württemberg, Germany
- +2 more
Jul 11, 2023
Reporting of Antibody-Drug Conjugate Associated Sepsis-related
Completed
- Sepsis (SMQ)
- +2 more
- Antibody-Drug Conjugate
- Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
-
Changsha, Hunan, ChinaCentral South University
Jun 19, 2022
Bladder Carcinoma in Situ (CIS) Trial (ONCOFID P-B (PACLITAXEL-HYALURONIC ACID))
Recruiting
- Bladder Carcinoma in Situ (CIS)
- ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
-
New Orleans, LouisianaOchsner Clinic Foundation
Jan 18, 2023
Acute Ischemic Stroke, Type 2 Diabetes Trial in Guangzhou (Urinary Kallidinogenase for injection, Placebo)
Not yet recruiting
- Acute Ischemic Stroke
- Type 2 Diabetes
- Urinary Kallidinogenase for injection
- Placebo
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital, Sun Yat-sen University
Oct 13, 2023
Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)
Recruiting
- Type 1 Diabetes
- ECP regular-intensity arm
- +2 more
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
Oct 28, 2022